BPGAM
CELU icon

BTG Pactual Global Asset Management’s Celularity CELU Stock Holding History

BTG Pactual Global Asset Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,500
Closed -$255K – 161
2021
Q2 		$255K Hold
2,500
– – 0.07% 58
2021
Q1 		$252K Buy
+2,500
New +$256K 0.07% 62

Other funds holding CELU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BTG Pactual Global Asset Management's CELU Position: Q3 2021 in Review

BTG Pactual Global Asset Management sold out of Celularity (CELU) in Q3 2021, closing a stake of 2,500 shares — an estimated $255K sold.

BTG Pactual Global Asset Management first reported a position in CELU in Q1 2021 and held it in 2 quarters. The position peaked at $255K in Q2 2021. 21 funds tracked by Wall St. Rank hold CELU as of Q3 2021.

  • BTG Pactual Global Asset Management reported no remaining Celularity position as of Q3 2021 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 2,500 Celularity shares in Q3 2021, an estimated $255K.
  • BTG Pactual Global Asset Management first reported a position in Celularity in Q1 2021 and held it in 2 quarters.
  • BTG Pactual Global Asset Management's Celularity position peaked at $255K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Celularity as of Q3 2021.

Based on BTG Pactual Global Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.